WGS
GeneDx Holdings Corp. Class A Common Stock
SERVICES-HEALTH SERVICES
Best Health Services Stocks 2026 →
GeneDx (WGS) Stock: Buy, Sell, or Hold?
$55.12
+0.29 (+0.53%)
▲
5d:
-20.51%
30d:
-15.15%
90d:
-30.36%
Open in Live Scanner
70/30 Portfolio Builder
Earnings: Nov 09, 2026
0d
Protect WGS Gains
Updated Nov 11, 12:00 AM ET
QUANTITATIVE VERDICT
HOLD
MODERATE Confidence (80%)
Quality Score
55/100
Position
OVERSOLD
30-Day Fair Range
$61.94 – $70.99
Position: OVERSOLD
Forward P/E & Valuation
53.9x
CHEAP
vs 96.9x historical avg
Wall Street Target
$91.00
+65.1% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$52.89 / $71.50
Trend: Strong Uptrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 HOLD: WGS shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Smart Money Distribution
Options positioning is turning defensive after a sharp run-up - a pattern consistent with institutional profit-taking. View Scanner →
Signal fired Nov 9, 2026 at $65.61 · last confirmed Nov 9, 2026
Strength: 6.7/10
Get Alerted When WGS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$49.78
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$30.91
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: WGS is currently trading at $55.12, which is considered oversold relative to its 30-day fair value range of $61.94 to $70.99. From a valuation perspective, the stock is trading at a discount (Forward PE: 53.9) compared to its historical average (96.9). Remarkably, the market is currently pricing in an annual earnings decline of 17.8% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, WGS is in a strong uptrend. Immediate support is located at $52.89, while resistance sits at $71.50.
Market Sentiment: The stock scores a mixed 50/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $91.00 (+65.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, WGS is in a strong uptrend. Immediate support is located at $52.89, while resistance sits at $71.50.
Market Sentiment: The stock scores a mixed 50/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $91.00 (+65.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$61.94 -
$70.99
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
79.5%
Trading Range & Key Levels
30-Day Trading Range
$61.94 -
$70.99
Current vs Trading Range
OVERSOLD
Support Level
$52.89
Resistance Level
$71.50
Current Trend
Strong Uptrend
Technical data as of
Nov 11, 2026
Protect Your Profits
Holding WGS? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanQuantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (50/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 65.1% below Wall St target ($91.00)
- NEUTRAL: Bottoming setup forming (50/100) — watch for confirmation
- CAUTION: 5-day price weakness (-20.5%) - monitor closely
Fundamental Context
Forward P/E (Next Year Est.)
53.91
Wall Street Target
$91.00
(+65.1%)
Revenue Growth (YoY)
5.4%
Profit Margin
-24.1%
Valuation Discount vs History
-17.8% cheaper
PE vs Historical
53.9 vs 96.9
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-17.8%
(market-implied from PE analysis)
1-Year Target
$49.61
(-10%)
2-Year Target
$44.65
(-19%)
3-Year Target
$40.18
(-27%)
3-Yr Target (if PE normalizes)
(PE: 54→97)
$72.23
(+31%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 53.9, Growth: 851.2%)
$186.03
(+238%)
Base:
(SPY PE: 19.9, Growth: 851.2%)
$68.54
(+24%)
Bear:
(PE: 16.9, Growth: 851.2%)
$58.26
(+6%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 53.9 to 96.9
Stabilization Target:
$99.08
(+79.8%)
PE Expansion Potential:
+79.8%
Share WGS Analysis
Share this live WGS analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (WGS)
Bullish
2 Retail Mentions
Reddit / WSB Comments
1
Bullish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 12, 2026
Daily AI digest
AI Retail Discussion Summary:
GeneDx (WGS) announced participation in upcoming investor conferences.
Key Retail Themes:
GeneDx management will present at two investor conferences in November and December.
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 11, 2026 8:58 PM ET
Data refreshes hourly during market hours. Next update: 9:58 PM
Data refreshes hourly during market hours. Next update: 9:58 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is WGS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
GH
Guardant Health Inc |
STRONG BUY
26 analysts |
$201 | 51 HOLD |
|
NTRA
Natera Inc |
STRONG BUY
23 analysts |
$416 | 65 BUY |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 52 HOLD |
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
27 analysts |
$752 | 47 HOLD |
|
DHR
Danaher Corporation |
STRONG BUY
24 analysts |
$260 | 51 HOLD |
Advanced WGS Option Strategies
Professional options setups generated by AI based on today's WGS price and gamma walls.
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive WGS Research Pages
